AI Engines For more Details: Perplexity Kagi Labs You
Growth Promotion: The primary intended effect of MGA in livestock is to promote weight gain and improve feed efficiency. By acting as a synthetic progestin, MGA can alter the hormonal balance in animals, leading to increased appetite and enhanced nutrient utilization, which ultimately results in accelerated growth rates.
Reproductive Effects: In female animals, MGA can exert contraceptive effects by inhibiting ovulation and disrupting normal estrous cycling. This property is often utilized in beef cattle production to suppress estrus in feedlot heifers, allowing for more efficient weight gain and improved carcass quality. However, prolonged exposure to MGA may disrupt reproductive function and fertility in livestock.
Hormonal Disruption: MGA belongs to the class of compounds known as endocrine disruptors, which have the potential to interfere with hormonal signaling pathways in animals. Chronic exposure to MGA may disrupt the normal functioning of the endocrine system, leading to various adverse effects on metabolism, growth, and reproductive health.
Residue Concerns: The use of MGA in livestock production raises concerns about the presence of residues in meat products intended for human consumption. While regulatory agencies establish maximum residue limits (MRLs) for MGA in food products, there is ongoing debate about the potential health risks associated with long-term exposure to low levels of MGA residues in meat.
Environmental Contamination: MGA, like other veterinary drugs, can enter the environment through the excretion of treated animals and the disposal of manure. There is potential for MGA residues to contaminate soil, water, and vegetation, posing risks to non-target organisms and ecosystems.
Antibiotic Combination Products: In some cases, MGA is formulated in combination with antibiotics (e.g., MGA/Terramycin). The use of antibiotic combination products raises additional concerns about antimicrobial resistance and the potential for the development of drug-resistant bacteria.
Rank | Probiotic | Impact |
---|---|---|
genus | Bacillus | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Blautia hansenii | Reduces |
species | Blautia wexlerae | Reduces |
species | Christensenella minuta | Reduces |
species | Enterococcus faecium | Reduces |
species | Escherichia coli | Reduces |
species | Lactococcus cremoris | Reduces |
species | Parabacteroides distasonis | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Coprococcus | genus | Decreases |
0 | 1 | Bilophila | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Phocaeicola | genus | Decreases |
0 | 1 | Catenibacterium | genus | Decreases |
0 | 1 | Segatella | genus | Decreases |
0 | 1 | Thomasclavelia | genus | Decreases |
0 | 1 | Eubacterium | genus | Decreases |
0 | 1 | Wujia | genus | Decreases |
0 | 1 | Ligilactobacillus | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Lachnoanaerobaculum | genus | Decreases |
0 | 1 | Eggerthella | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Chordicoccus | genus | Decreases |
0 | 1 | Intestinibaculum | genus | Decreases |
0 | 1 | Oscillibacter | genus | Decreases |
0 | 1 | Mageeibacillus | genus | Decreases |
0 | 1 | Pseudobutyrivibrio | genus | Decreases |
0 | 1 | Faecalibacillus | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 1 | Monoglobus | genus | Decreases |
0 | 1 | Subdoligranulum | genus | Decreases |
0 | 1 | Adlercreutzia | genus | Decreases |
0 | 1 | Simiaoa | genus | Decreases |
0 | 1 | Wansuia | genus | Decreases |
0 | 1 | Acutalibacter | genus | Decreases |
0 | 1 | Lactococcus | genus | Decreases |
0 | 1 | Anaerobutyricum | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Fannyhessea | genus | Decreases |
0 | 1 | Faecalibaculum | genus | Decreases |
0 | 1 | Vescimonas | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Komagataeibacter | genus | Decreases |
0 | 1 | Christensenella | genus | Decreases |
0 | 1 | Butyrivibrio | genus | Decreases |
0 | 1 | Olsenella | genus | Decreases |
0 | 1 | Bacillus | genus | Decreases |
0 | 1 | Maliibacterium | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Faecalitalea | genus | Decreases |
0 | 1 | Faecalibacterium | genus | Decreases |
0 | 1 | Parvimonas | genus | Decreases |
0 | 1 | Massilistercora | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Novisyntrophococcus | genus | Decreases |
0 | 1 | Treponema | genus | Decreases |
0 | 1 | Turicibacter | genus | Decreases |
0 | 1 | Lawsonibacter | genus | Decreases |
0 | 1 | Anaerotruncus | genus | Decreases |
0 | 1 | Qiania | genus | Decreases |
0 | 1 | Aminipila | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Bilophila wadsworthia | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
1 | 0 | Coprococcus comes | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
1 | 0 | Parabacteroides distasonis | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Phocaeicola vulgatus | species | Decreases |
1 | 0 | Segatella copri | species | Decreases |
1 | 0 | Thomasclavelia ramosa | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
1 | 0 | Eggerthella lenta | species | Decreases |
0 | 1 | Blautia obeum | species | Decreases |
0 | 1 | Dorea formicigenerans | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Lacrimispora saccharolytica | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | [Ruminococcus] torques | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Treponema peruense | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Catenibacterium sp. co_0103 | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Roseburia hominis | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Faecalibacterium sp. I2-3-92 | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
0 | 1 | Faecalibacterium sp. HTF-F | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-1-79 | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-3-29 | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-89 | species | Decreases |
0 | 1 | Ruminococcus bicirculans (ex Wegman et al. 2014) | species | Decreases |
0 | 1 | Mageeibacillus indolicus | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-1-18 | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Solibaculum mannosilyticum | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | Chordicoccus furentiruminis | species | Decreases |
0 | 1 | Oscillibacter hominis | species | Decreases |
0 | 1 | Monoglobus pectinilyticus | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-3-84 | species | Decreases |
0 | 1 | Roseburia rectibacter | species | Decreases |
0 | 1 | Adlercreutzia hattorii | species | Decreases |
0 | 1 | Vescimonas coprocola | species | Decreases |
0 | 1 | Roseburia intestinalis | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Blautia wexlerae | species | Decreases |
0 | 1 | Blautia argi | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | Acutalibacter muris | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-33 | species | Decreases |
0 | 1 | Segatella bryantii | species | Decreases |
0 | 1 | Eubacterium sp. c-25 | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Alistipes sp. dk3624 | species | Decreases |
0 | 1 | Bacteroides sp. D2 | species | Decreases |
0 | 1 | Bacteroides sp. DH3716P | species | Decreases |
0 | 1 | Enterococcus cecorum | species | Decreases |
0 | 1 | Lawsonibacter asaccharolyticus | species | Decreases |
0 | 1 | Faecalibaculum rodentium | species | Decreases |
0 | 1 | Enterococcus faecium | species | Decreases |
0 | 1 | Ruminococcus bovis | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Simiaoa sunii | species | Decreases |
0 | 1 | Pusillibacter faecalis | species | Decreases |
0 | 1 | Treponema denticola | species | Decreases |
0 | 1 | Eggerthella guodeyinii | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
0 | 1 | Bacteroides sp. M10 | species | Decreases |
0 | 1 | Leyella stercorea | species | Decreases |
0 | 1 | Lachnospira eligens | species | Decreases |
0 | 1 | Intestinimonas butyriciproducens | species | Decreases |
0 | 1 | Bacteroides faecium | species | Decreases |
0 | 1 | Emergencia timonensis | species | Decreases |
0 | 1 | Eubacterium limosum | species | Decreases |
0 | 1 | Anaerotruncus colihominis | species | Decreases |
0 | 1 | Flintibacter sp. KGMB00164 | species | Decreases |
0 | 1 | Ruminococcus albus | species | Decreases |
0 | 1 | Phascolarctobacterium sp. Marseille-Q4147 | species | Decreases |
0 | 1 | Turicibacter bilis | species | Decreases |
0 | 1 | Corynebacterium durum | species | Decreases |
0 | 1 | Eubacterium maltosivorans | species | Decreases |
0 | 1 | [Eubacterium] hominis | species | Decreases |
0 | 1 | Phascolarctobacterium succinatutens | species | Decreases |
0 | 1 | Butyrivibrio fibrisolvens | species | Decreases |
0 | 1 | Clostridioides difficile | species | Decreases |
0 | 1 | Eubacterium callanderi | species | Decreases |
0 | 1 | Olsenella sp. oral taxon 807 | species | Decreases |
0 | 1 | Blautia hansenii | species | Decreases |
0 | 1 | Romboutsia ilealis | species | Decreases |
0 | 1 | Butyricicoccus sp. GAM44 | species | Decreases |
0 | 1 | Alistipes indistinctus | species | Decreases |
0 | 1 | Blautia parvula | species | Decreases |
0 | 1 | Bacteroides caecimuris | species | Decreases |
0 | 1 | Phoenicibacter congonensis | species | Decreases |
0 | 1 | Dysosmobacter welbionis | species | Decreases |
0 | 1 | Actinomyces naeslundii | species | Decreases |
0 | 1 | Blautia producta | species | Decreases |
0 | 1 | Blautia pseudococcoides | species | Decreases |
0 | 1 | Ruthenibacterium lactatiformans | species | Decreases |
0 | 1 | [Clostridium] scindens | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
1 | 0 | Parabacteroides merdae | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.6 | 0.1 | 5 |
ADHD | 0.9 | 1.5 | -0.67 |
Age-Related Macular Degeneration and Glaucoma | 0.5 | 0.1 | 4 |
Allergic Rhinitis (Hay Fever) | 1.4 | 0.5 | 1.8 |
Allergies | 2.6 | 1.4 | 0.86 |
Allergy to milk products | 1.4 | 0.8 | 0.75 |
Alopecia (Hair Loss) | 0.9 | 0.2 | 3.5 |
Alzheimer's disease | 3.5 | 4.1 | -0.17 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 1.3 | 0.5 | 1.6 |
Ankylosing spondylitis | 1.7 | 1.2 | 0.42 |
Anorexia Nervosa | 0.5 | 1.2 | -1.4 |
Antiphospholipid syndrome (APS) | 0.3 | 0.3 | 0 |
Asthma | 1.5 | 0.7 | 1.14 |
Atherosclerosis | 1 | 0.7 | 0.43 |
Atrial fibrillation | 1.5 | 1.6 | -0.07 |
Autism | 4.9 | 4.5 | 0.09 |
Autoimmune Disease | 0 | 0.4 | 0 |
benign prostatic hyperplasia | 0 | 0.3 | 0 |
Biofilm | 0.6 | 0.6 | |
Bipolar Disorder | 1.4 | 1.1 | 0.27 |
Brain Trauma | 0.3 | 0.9 | -2 |
Breast Cancer | 0 | 0 | |
Cancer (General) | 0.8 | -0.8 | |
Carcinoma | 2.2 | 1.5 | 0.47 |
Celiac Disease | 1.2 | 1.5 | -0.25 |
Cerebral Palsy | 0.5 | 0.6 | -0.2 |
Chronic Fatigue Syndrome | 2.7 | 5.1 | -0.89 |
Chronic Kidney Disease | 2.6 | 2 | 0.3 |
Chronic Lyme | 0.1 | 0.3 | -2 |
Chronic Obstructive Pulmonary Disease (COPD) | 0.8 | 0.9 | -0.13 |
Chronic Urticaria (Hives) | 0.2 | 0.7 | -2.5 |
Coagulation / Micro clot triggering bacteria | 0.4 | 0.9 | -1.25 |
Cognitive Function | 1.3 | 0.7 | 0.86 |
Colorectal Cancer | 2.7 | 1.1 | 1.45 |
Constipation | 0.9 | 0.3 | 2 |
Coronary artery disease | 1.4 | 2.2 | -0.57 |
COVID-19 | 4 | 7.4 | -0.85 |
Crohn's Disease | 5 | 3.6 | 0.39 |
Cushing's Syndrome (hypercortisolism) | 0.6 | -0.6 | |
cystic fibrosis | 0.1 | 0.4 | -3 |
d-lactic acidosis (one form of brain fog) | 0 | 0 | |
deep vein thrombosis | 0.9 | 1.1 | -0.22 |
Denture Wearers Oral Shifts | 0.1 | 0.1 | |
Depression | 5.7 | 3.7 | 0.54 |
Dermatomyositis | 0.1 | -0.1 | |
Eczema | 0.8 | 0.5 | 0.6 |
Endometriosis | 1.5 | 1.1 | 0.36 |
Eosinophilic Esophagitis | 0.1 | -0.1 | |
Epilepsy | 1.2 | 0.6 | 1 |
erectile dysfunction | 0.5 | 0.1 | 4 |
Fibromyalgia | 1.5 | 1.7 | -0.13 |
Functional constipation / chronic idiopathic constipation | 3.3 | 3 | 0.1 |
gallstone disease (gsd) | 1.7 | 0.4 | 3.25 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.6 | 1.1 | -0.83 |
Generalized anxiety disorder | 1.4 | 1.1 | 0.27 |
giant cell arteritis | 0.1 | -0.1 | |
Glioblastoma | 0.2 | 0.1 | 1 |
Gout | 1.4 | 0.6 | 1.33 |
Graves' disease | 0.5 | 0.8 | -0.6 |
Gulf War Syndrome | 0.6 | 0.3 | 1 |
Halitosis | 0.6 | 0.6 | |
Hashimoto's thyroiditis | 1.6 | 1.1 | 0.45 |
Heart Failure | 2.5 | 1.3 | 0.92 |
hemorrhagic stroke | 0.5 | 0.5 | |
Hidradenitis Suppurativa | 0.7 | 0.7 | |
High Histamine/low DAO | 0.6 | 0.3 | 1 |
hypercholesterolemia (High Cholesterol) | 0.2 | 0.3 | -0.5 |
hyperglycemia | 0.3 | 0.3 | 0 |
Hyperlipidemia (High Blood Fats) | 0.8 | 0.1 | 7 |
hypersomnia | 0.5 | -0.5 | |
hypertension (High Blood Pressure | 2 | 3.2 | -0.6 |
Hypothyroidism | 0.1 | 1 | -9 |
Hypoxia | 1 | 1 | |
IgA nephropathy (IgAN) | 0.8 | 2.3 | -1.87 |
Inflammatory Bowel Disease | 4.8 | 5 | -0.04 |
Insomnia | 1.4 | 0.9 | 0.56 |
Intelligence | 0.8 | 0.9 | -0.13 |
Intracranial aneurysms | 0.6 | 0.8 | -0.33 |
Irritable Bowel Syndrome | 2.5 | 3.1 | -0.24 |
ischemic stroke | 0.5 | 0.6 | -0.2 |
Juvenile idiopathic arthritis | 0.1 | 0.2 | -1 |
Liver Cirrhosis | 3.5 | 2.6 | 0.35 |
Long COVID | 4.7 | 4.1 | 0.15 |
Low bone mineral density | 0.1 | 1.3 | -12 |
Lung Cancer | 0.8 | 0.6 | 0.33 |
Lymphoma | 0 | 0.1 | 0 |
Mast Cell Issues / mastitis | 0 | 0.7 | 0 |
ME/CFS with IBS | 0.1 | 2.6 | -25 |
ME/CFS without IBS | 1.7 | 1.5 | 0.13 |
Menopause | 0.7 | 0.4 | 0.75 |
Metabolic Syndrome | 5.5 | 4.5 | 0.22 |
Mood Disorders | 5.3 | 2.9 | 0.83 |
Multiple Sclerosis | 2.5 | 3.8 | -0.52 |
Multiple system atrophy (MSA) | 0.2 | 0.2 | 0 |
myasthenia gravis | 0.1 | 0.5 | -4 |
neuropathic pain | 0.2 | 0.8 | -3 |
Neuropathy (all types) | 0.3 | 0.3 | 0 |
neuropsychiatric disorders (PANDAS, PANS) | 0 | 0.2 | 0 |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 3 | 2.6 | 0.15 |
NonCeliac Gluten Sensitivity | 0.4 | 0.3 | 0.33 |
Obesity | 6.3 | 4.6 | 0.37 |
obsessive-compulsive disorder | 2.8 | 2.4 | 0.17 |
Osteoarthritis | 1.9 | 0.9 | 1.11 |
Osteoporosis | 0.9 | 0.7 | 0.29 |
Parkinson's Disease | 3.9 | 4.3 | -0.1 |
Polycystic ovary syndrome | 3.8 | 1.1 | 2.45 |
Postural orthostatic tachycardia syndrome | 0.1 | 0.5 | -4 |
Premenstrual dysphoric disorder | 0.1 | -0.1 | |
primary biliary cholangitis | 0.3 | 0.2 | 0.5 |
Primary sclerosing cholangitis | 0.6 | 3 | -4 |
Psoriasis | 1 | 2.2 | -1.2 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 4.3 | 1.8 | 1.39 |
Rosacea | 0.4 | 0.3 | 0.33 |
Schizophrenia | 2.9 | 1.9 | 0.53 |
scoliosis | 1 | 0.7 | 0.43 |
sensorineural hearing loss | 0.5 | 0.5 | |
Sjögren syndrome | 0.8 | 0.7 | 0.14 |
Sleep Apnea | 1.1 | 1.1 | 0 |
Slow gastric motility / Gastroparesis | 0.6 | 0.1 | 5 |
Small Intestinal Bacterial Overgrowth (SIBO) | 1.1 | 1.1 | |
Stress / posttraumatic stress disorder | 1 | 1.5 | -0.5 |
Systemic Lupus Erythematosus | 2.5 | 1 | 1.5 |
Tic Disorder | 0.7 | 1.3 | -0.86 |
Tourette syndrome | 0.1 | 0.2 | -1 |
Type 1 Diabetes | 2.6 | 1.9 | 0.37 |
Type 2 Diabetes | 5.4 | 3.2 | 0.69 |
Ulcerative colitis | 3.2 | 4.7 | -0.47 |
Unhealthy Ageing | 2.8 | 1.1 | 1.55 |
Vitiligo | 1.2 | 0.9 | 0.33 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]